BlackRock Investment Management, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2016$1,839,000
+7.5%
17,473
+12.9%
0.00%0.0%
Q3 2016$1,711,000
-23.7%
15,482
+0.6%
0.00%
-33.3%
Q2 2016$2,241,000
+129.6%
15,390
+125.8%
0.00%
+200.0%
Q1 2016$976,000
+9.4%
6,816
+18.1%
0.00%0.0%
Q4 2015$892,000
+9811.1%
5,770
+9359.0%
0.00%
Q3 2015$9,000610.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2016
NameSharesValueWeighting ↓
HealthInvest Partners AB 78,905$8,306,0007.65%
FORT, L.P. 157,584$16,589,0004.68%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 808,200$85,079,0004.39%
Strategic Global Advisors, LLC 81,432$8,572,0003.18%
Prince Street Capital Management LLC 48,700$5,127,0001.62%
Analyst IMS Investment Management Services Ltd. 31,438$3,309,0001.45%
Freestone Capital Holdings, LLC 84,900$8,937,0000.77%
RPG Investment Advisory, LLC 17,227$1,813,0000.61%
CLINTON GROUP INC 46,370$4,881,0000.28%
USA FINANCIAL FORMULAS 10,786$1,135,0000.28%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders